Abstract 69P
Background
Oral Squamous Cell Carcinoma (OSCC) remains a significant health burden globally, necessitating a comprehensive understanding of its underlying molecular mechanisms. Hypoxia, a hallmark of solid tumors, profoundly influences cancer progression, therapeutic response, and major cause of reoccurrence. This study aimed to elucidate the metabolic alterations associated with hypoxia-induced OSCC cell lines using a proteomics and metabolomics approach.
Methods
Human OSCC cell lines were cultured under normoxic and hypoxic conditions. Hypoxia induction was validated by western blot. Cell proliferation and migration were observed by MTT assay and scratch assay respectively. Subsequently, proteomics and metabolomics were employed. Bioinformatic tools were used to analyze the data, identifying key metabolic pathways affected by hypoxia in OSCC cells. Further, TCGA data was used for identify the enriched pathway in different Hypoxia enriched cluster through ssGSEA, GSEA, and differential analysis.
Results
Integrated analysis of the OMIC data revealed substantial alterations in arginine and proline metabolism in OSCC cells subjected to hypoxic conditions. The expression levels of key enzymes involved in these metabolic pathways, such as argininosuccinate synthase 1 (ASS1) were significantly dysregulated. Furthermore, downstream metabolites, including ornithine and polyamines; spermidine, and spermine exhibited significant changes under hypoxic stress. These alterations suggested a potential critical role of arginine and proline metabolism in OSCC adaptation to hypoxic stress. Further, TCGA data analysis reveals cell proliferative, migration, angiogenesis, and EMT pathways are enriched in high hypoxic score clusters. Clusters showing high hypoxia enrichment scores have a low survival rate.
Conclusions
This integrated OMIC analysis sheds light on the dysregulation of Arginine and proline metabolism and other cancer-specific pathways that may contribute to tumor adaptation and survival under low-oxygen conditions. Understanding the metabolic rewiring in hypoxia-driven OSCC could unveil new therapeutic targets and strategies for combating this aggressive malignancy.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
94P - Harnessing circulating tumor DNA in bronchoalveolar lavage fluid for precise molecular diagnosis of NSCLC
Presenter: Frank Borm
Session: Cocktail & Poster Display session
Resources:
Abstract
95P - Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)
Presenter: Betzabel Cajiao Garcia
Session: Cocktail & Poster Display session
Resources:
Abstract
96P - Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients
Presenter: Simona Duranti
Session: Cocktail & Poster Display session
Resources:
Abstract
97P - Prospects of liquid biopsy in determining prognosis in children with HGG and DIPG
Presenter: Olga Regentova
Session: Cocktail & Poster Display session
Resources:
Abstract
98P - Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response
Presenter: Ana Fernández
Session: Cocktail & Poster Display session
Resources:
Abstract
99P - Comprehensive genomic sequencing as an ancillary diagnostic tool for pathologists
Presenter: Dan Miller
Session: Cocktail & Poster Display session
Resources:
Abstract
100P - Standard serum biomarkers to help predict a cancer diagnosis in patients with non-specific symptoms: Data from Guy´s rapid diagnostic clinic
Presenter: Maria Monroy Iglesias
Session: Cocktail & Poster Display session
Resources:
Abstract
101P - Patient-derived organoids to optimize CDK4/6 inhibitor-based treatment selection in early breast cancer
Presenter: Carla Alves
Session: Cocktail & Poster Display session
Resources:
Abstract
102P - MicroRNAs in urine and saliva as non-invasive biomarkers of minimal residual disease in pediatric acute lymphoblastic leukemia
Presenter: Alejandra Pando-Caciano
Session: Cocktail & Poster Display session
Resources:
Abstract
103P - MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract